Archives for 

U.S. Supreme Court Decisions

MYLAN, APOTEX, COHERUS, AND ADELLO FILE AMICUS BRIEFS IN SANDOZ V. AMGEN

Amgen v. Sandoz (filgrastim)  •  Patent Dance  •  U.S. Biosimilar Litigation News  •  U.S. Supreme Court Decisions
As we covered in previous posts, the Supreme Court will hear arguments regarding the Federal Circuit’s interpretation of the BPCIA’s notice of commercial marketing requirement and patent dance provisions in April 2017.  Several amicus briefs in support […]

View More

Supreme Court Announces Briefing Schedule in Amgen v. Sandoz

Amgen v. Sandoz (pegfilgrastim)  •  BPCIA and Related U.S. Statutes  •  Patent Dance  •  U.S. Biosimilar Litigation News  •  U.S. Supreme Court Decisions
The Supreme Court has ordered a briefing schedule in Amgen v. Sandoz. Because the Court granted and consolidated Sandoz’s petition and Amgen’s conditional cross-petition, the Court has adopted a four-brief schedule, comparable to the […]

View More

Year in Review: The Top-Five Legal Developments of 2016

Amgen v. Apotex (pegfilgrastim)  •  Amgen v. Sandoz (filgrastim)  •  Biosimilar News  •  BPCIA and Related U.S. Statutes  •  Patent Dance  •  PTAB + IPR  •  Reimbursement  •  Reimbursement  •  U.S. Biosimilar Litigation News  •  U.S. Federal Circuit Decisions  •  U.S. Supreme Court Decisions
Here are our picks for the top-five most significant legal developments in the world of biosimilars in 2016: 5) Congress passed and President Obama signed the 21st Century Cures Act.  Among other things, […]

View More

BREAKING NEWS: SOLICITOR GENERAL FILES BRIEF RECOMMENDING SUPREME COURT HEAR SANDOZ V. AMGEN

Amgen v. Sandoz (filgrastim)  •  Biosimilar News  •  BPCIA and Related U.S. Statutes  •  Patent Dance  •  U.S. Biosimilar Litigation News  •  U.S. Federal Circuit Decisions  •  U.S. Supreme Court Decisions
The Acting Solicitor General has just filed an amicus brief recommending that Sandoz’s cert petition and Amgen’s cross-petition be granted.  The Acting Solicitor General also argues that the decision by the Federal Circuit on the 180-day […]

View More